Biobanking Clinical Trials Life Science Medicine 
Drug Discovery World
NOVEMBER 23, 2023
Narain , PhD, President and CEO of BPGbio asks how a better calibre of biobanks in life sciences can lead to more drugs making it to market. We eagerly await future data read-outs from trials because after all, it is the drug that patients are waiting for, not our fancy algorithms. But the utility of biobanks varies.
Drug Discovery World
MAY 16, 2024
million development in Manchester intended to enhance the city’s Oxford Road Corridor knowledge quarter as a hub for life sciences and technology innovation. Greenheys at Manchester Science Park is scheduled for completion in Summer 2026 and will span 131,000 sq ft across six floors. Work has started on a £60 ($75.1)
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JULY 5, 2022
I recently had the pleasure of attending the PING Conference 2022 , which had the tagline of ‘The Golden Age for Life Sciences Innovation’. Aspirations for the UK in life sciences. Reducing complexity across the NHS. Accelerating access for patients.
The Pharma Data
JULY 12, 2021
online issue of Nature Communications, researchers at University of California San Diego School of Medicine describe a new approach that uses machine learning to hunt for disease targets and then predicts whether a drug is likely to receive FDA approval. “Academic labs and pharmaceutical and? the success rates in drug discovery?are
The Pharma Data
APRIL 11, 2023
BAY 2927088 is a reversible small molecule inhibitor that is currently being evaluated in a first-in-human, Phase 1 clinical trial in non-small cell lung cancer (NSCLC) patients with mutations in epidermal growth factor receptors (EGFR & HER2) including exon20 insertions and point mutations.
XTalks
FEBRUARY 4, 2021
The power of leveraging clinical data to decipher disease mechanisms and fuel drug discovery has rapidly grown in the era of genomics and personalized medicine. Generation of strong research dataset cohorts must begin with high-quality clinical samples. Partnerships and Establishing Research Cohorts.
The Pharma Data
JANUARY 31, 2021
The life sciences ecosystem will need to capitalize on this momentum going forward to solve other diseases that will define the 21 st century. . We’re trying to do that for the world of biospecimens and life science research,” iSpecimen Founder and Chief Executive Officer Dr. Chris Ianelli told BioSpace.
Expert insights. Personalized for you.
59 
Let's personalize your content